Sagility Shares Surge After Q2 Results and Brokerage Upgrades
Sagility stock has surged after brokerages upgraded guidance (Image Sagility Facebook page)
The BPO and healthcare solutions firm rallies on strong earnings, guidance upgrades, and AI-driven growth optimism; analysts see sustained upside despite short-term consolidation.
By S JHA
Mumbai, November 1, 2025 — Shares of Sagility Ltd have surged nearly 21% in the past month, buoyed by a robust Q2FY26 earnings report, upbeat brokerage commentary, and rising investor confidence in the company’s AI-led growth strategy.
The stock, currently trading around ₹54.58, has climbed sharply from ₹42, marking a strong uptrend. Investor Arepalli Kiran noted on X, “The stock price has shown a clear and strong upward trend, rising from approximately ₹42 to ₹54.58.”
According to Business Upturn, Sagility shares rallied over 9% after the company reported a 68.9% QoQ jump in net profit to ₹251 crore and a 7.8% rise in revenue to ₹1,658 crore.
Market analyst Aadesh Jain said, “Sagility has delivered superb results again. Many were selling due to tariff war fears — had highlighted multiple times it has no relation. Hoping it should cross all-time highs soon.”
Investor sentiment turned particularly bullish after ICICI Securities reiterated a ‘BUY’ rating on the stock with a target price of ₹65, citing strong guidance and operational performance. The brokerage highlighted Sagility’s FY26 revenue growth forecast of 21%+, EBITDA margins of 25%, and plans to clear all external borrowings by FY27.
The company also announced its first dividend since listing, showing confidence in cash flows. Analysts point to robust hiring — over 4,300 recruits in H1FY26 — and growing AI adoption across 25 use cases as major structural positives.
While short-term traders expect the stock to consolidate between ₹45–₹52, long-term investors remain optimistic. “Sagility’s fundamentals are solid,” wrote Abhishek Bansal, “and with management maintaining this growth rate, further repricing toward mid-50s and beyond is likely.”
With strong financials, debt discipline, and GenAI integration, analysts hope that Sagility’s rally may just be the start of a longer-term re-rating story in India’s tech-enabled healthcare services space. Screener’s description for the company reads as: “Incorporated in July 2021, Sagility India Limited (formerly Berkmeer India Pvt. Ltd) provides healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.”
The face value of the stock is ₹10. The RoE and RoCE of Sagility stand at 7.38 and 9.58 respectively. The market cap of the company currently stands at ₹24596 crores.
(This article makes no recommendation for buy or sell of shares of any company)
Follow The Raisina Hills on WhatsApp, Instagram, YouTube, Facebook, and LinkedIn